Alar Pharmaceuticals Competitors and Similar CompaniesClear all

Alar Pharmaceuticals's competitors and similar companies include Curyx Partners Therapeutics, Precision Diagnostics, M3 and APTEEUS.

	Alar Pharmaceuticals Alar Pharmaceuticals is a new drug development company.	Curyx Partners Therapeutics Curyx Partners Therapeutics Holdings is a company that offers drug development solutions.	Precision Diagnostics Precision Diagnostics is a clinical laboratory that provides precision testing, analytics, and billing services.	M3 M3 is a medical care services providing company.	APTEEUS APTEEUS is a biotech specialized in drug discovery and repositioning.
Founding Date	Founding Date 2016	Founding Date N/A	Founding Date 2013	Founding Date 2000	Founding Date 2013
Type	Type Public	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare drug development medical diagnostics	Tags Healthcare drug development medical diagnostics	Tags Healthcare drug development medical diagnostics	Tags Healthcare drug development medical diagnostics	Tags Healthcare drug development medical diagnostics
Locations	Locations HQ	Locations Hong Kong, HK HQ	Locations San Diego, US HQ Dartmouth, US	Locations Tokyo, JP HQ	Locations Roubaix, FR HQ Lille, FR
Employees	Employees N/A	Employees N/A	Employees 261	Employees 12,100	Employees 4
Financial
Revenue (est.)	Revenue (est.) NT$2.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥284.9b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods NT$613k (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥128.9b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit NT$2.8m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit ¥156.8b (FY, 2025)	Gross profit N/A
Net income	Net income (NT$79.7m) (FY, 2025)	Net income N/A	Net income N/A	Net income ¥44.3b (FY, 2025)	Net income N/A